Deals
Belgian biotechnology company sells drug discovery unit for EUR25 million
Brussels-based biotechnology company IBA concluded the sale of its drug discovery business unit to private equity firm Argos Soditic. IBA raised EUR25 million from the sale of Cisbio Bioassays.
CareFusion Corp enters agreement to purchase Vital Signs from General Electric unit for USD500 million
CareFusion Corp's acquisition of Vital Signs from GE Healthcare was considered strategic as the former aimed to expand its anesthesiology and respiratory care business while saving up to USD15 million in annual costs.
Investment in activist funds can be a high-stakes gamble - report
A Reuters report cautioned the risks involved in investing in activist funds like Pershing Square Capital Management because just as it can earn high returns, it could also result to massive losses.
RBS negotiates sale of equity derivatives business
British government-owned The Royal Bank of Scotland said it was looking to sell its retail investor and equity derivatives business. French bank BNP Paribas was identified as a front-runner to acquire the business unit.




